The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 11, 2023

Filed:

Dec. 07, 2020
Applicant:

Dexcom, Inc., San Diego, CA (US);

Inventors:

Andrew Scott Parker, San Diego, CA (US);

Annika Emilie Kristina Jimenez, Carlsbad, CA (US);

Chad Patterson, San Diego, CA (US);

Subrai Girish Pai, San Diego, CA (US);

Apurv Ullas Kamath, San Diego, CA (US);

Assignee:

Dexcom, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/145 (2006.01); G06N 3/08 (2023.01); A61B 5/00 (2006.01); G16H 40/67 (2018.01); G16H 50/50 (2018.01); G16H 10/60 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); G16H 50/20 (2018.01); A61B 5/16 (2006.01); G06Q 30/0201 (2023.01);
U.S. Cl.
CPC ...
A61B 5/14532 (2013.01); A61B 5/0004 (2013.01); A61B 5/0022 (2013.01); A61B 5/167 (2013.01); A61B 5/4833 (2013.01); A61B 5/4842 (2013.01); A61B 5/7264 (2013.01); A61B 5/7275 (2013.01); A61B 5/742 (2013.01); A61B 5/7475 (2013.01); G06N 3/08 (2013.01); G06Q 30/0201 (2013.01); G16H 10/60 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/50 (2018.01); G16H 50/70 (2018.01);
Abstract

Multi-state engagement with continuous glucose monitoring (CGM) systems is described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains packages of glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform generates state information for the user by processing these CGM packages and the additional data, at least in part, by using one or more models. Based on this state information, the data analytics platform controls communication with the user, which may include generating intervention strategies to prevent users from transitioning to a negative state such as discontinuing use of the CGM system.


Find Patent Forward Citations

Loading…